EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Drug‐Induced Liver Injury in Patients With Chronic Liver Disease

Marwan Ghabril iD, Raj Vuppalanchi, Naga Chalasani

Liver International · 2025-03 · 45 (3)

DOI: 10.1111/liv.70019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, online erschienen am 10.02.2025. Verfasst von Marwan Ghabril und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Liver Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Drug‐induced liver injury (DILI) is a global problem and can develop from exposure to prescription or over‐the‐counter medications as well as herbal and dietary supplements. The diagnosis of DILI is clinically challenging, and liver injury can be severe leading to liver failure, death, or liver transplantation. Patients with underlying chronic liver diseases (CLD) may be at increased risk for DILI, which is associated with factors related to drug or liver disease.

Methods

This review summarises current knowledge on the risk and outcomes of DILI in patients with CLD.

Results

Patients with CLD may be at an increased risk for DILI. Additionally patients with underlying CLD are at risk for more severe liver injury and worse outcomes after DILI.

Discussion

The risk for and poor outcomes from DILI are accentuated in patients with CLD and potentially leading to the worst‐case scenario of acute‐on‐chronic liver failure. We highlight the key observations on DILI with a broad range of underlying liver diseases and the high‐DILI risk agents implicated in those populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryLiver DiseasesHumansChronic DiseaseRisk FactorsAcute-On-Chronic Liver Failure

Stichwörter der Autor:innen

acute‐on‐chronic liver failurechronic liver diseasedrug‐induced liver injury

Autor:innen und Institutionen

  • Gastroenterology and Hepatology, Indiana University School of Medicine and Indiana University Health, Indianapolis, Indiana, USA.

ORCID-Profile: Marwan Ghabril

Zitieren

APA

Ghabril, M., Vuppalanchi, R., & Chalasani, N. (2025). Drug‐Induced Liver Injury in Patients With Chronic Liver Disease. Liver International, 45(3). https://doi.org/10.1111/liv.70019

Vancouver

Ghabril M, Vuppalanchi R, Chalasani N. Drug‐Induced Liver Injury in Patients With Chronic Liver Disease. Liver International. 2025;45(3). doi:10.1111/liv.70019

BibTeX
@article{Ghabril2025,
  author = {Ghabril, Marwan and Vuppalanchi, Raj and Chalasani, Naga},
  title = {Drug‐Induced Liver Injury in Patients With Chronic Liver Disease},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {3},
  doi = {10.1111/liv.70019}
}
Kostenlos starten →